Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT06566651
Eligibility Criteria:
Inclusion Criteria:
* ALS patients, ambulant and hospitalized
* Able to give informed consent
* Diagnosed with ALS or probable ALS according to the existing revision of the El Escorial Criteria 21,22.
* Patients with a peripheral neuromuscular disease, ambulant and hospitalized
* Able to give informed consent
* Diagnosed with a peripheral neuromuscular disease, that does not affect CNS, including but not limited to Myasthenia Gravis and polyneuropathy
* Healthy controls
* Able to give informed consent
* Age and gender matched to ALS patients
Exclusion Criteria:
* All Participants
* Other severe medical, neurological, or psychiatric disorders
* Visual impairment to an extent that interferes with the ability to perform of the test
* Severe motor or cognitive deficits, to the extent that the test-task cannot be performed
* Alcohol or drug abuse to an extent the interferes with task performance
* Patients with a peripheral neuromuscular disease
● Familial predisposition to ALS
* Healthy controls
* Familial predisposition to ALS (first degree relatives)
* Medical treatment that affects the central nervous system (e.g., antidepressants)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06566651
Study Brief:
Protocol Section:
NCT06566651